Dose-escalation Study to Assess Safety, Tolerability and Pharmacokinetics of MEDI-573 in Japanese Subjects
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to explore the safety and tolerability of MEDI-573 in
Japanese subjects with advanced solid tumours refractory to standard therapy or for which no
standard therapy exists.